Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 15, Issue -, Pages 1183-1196
Publisher
Informa UK Limited
Online
2023-10-27
DOI
10.2147/cmar.s404371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial
- (2023) David S. Hong et al. NATURE MEDICINE
- Metastatic adult‐type non‐rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group
- (2023) Andrea Ferrari et al. CANCER
- The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
- (2022) Pablo Berlanga et al. Cancer Discovery
- Primary efficacy and safety of letetresgene autoleucel (lete-cel; GSK3377794) pilot study in patients with advanced and metastatic myxoid/round cell liposarcoma (MRCLS).
- (2022) Sandra P. D'Angelo et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes following preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.
- (2022) Aaron R. Weiss et al. JOURNAL OF CLINICAL ONCOLOGY
- Relapsing pediatric non-rhabdomyosarcoma soft tissue sarcomas: The impact of routine imaging surveillance on early detection and post-relapse survival
- (2022) Carlo Morosi et al. EUROPEAN JOURNAL OF CANCER
- Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’
- (2022) Karin P.S. Langenberg et al. EUROPEAN JOURNAL OF CANCER
- Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
- (2022) Andrea Ferrari et al. Cancer Management and Research
- Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
- (2021) Livnat Jerby-Arnon et al. NATURE MEDICINE
- Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network
- (2021) Gonzague de Pinieux et al. PLoS One
- Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)
- (2021) A. Ferrari et al. ESMO Open
- Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
- (2021) Marcella Tazzari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IGNYTE-ESO: A master protocol to assess safety and activity of letetresgene autoleucel (lete-cel; GSK3377794) in HLA-A*02+ patients with synovial sarcoma or myxoid/round cell liposarcoma (Substudies 1 and 2).
- (2021) Sandra P. D'Angelo et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
- (2021) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting cancer testis antigens in synovial sarcoma
- (2021) Geoffrey Mitchell et al. Journal for ImmunoTherapy of Cancer
- Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)
- (2021) Andrea Ferrari et al. Lancet Child & Adolescent Health
- 959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA203 trial
- (2021) Martin Wermke et al. Journal for ImmunoTherapy of Cancer
- A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma
- (2020) Esther Baranov et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy
- (2020) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
- Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
- (2020) Aaron R Weiss et al. LANCET ONCOLOGY
- Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes
- (2020) Marc El Beaino et al. Current Oncology Reports
- The BAF complex in development and disease
- (2019) Amelie Alfert et al. Epigenetics & Chromatin
- A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
- (2019) Sally L. George et al. EUROPEAN JOURNAL OF CANCER
- Soft tissue sarcoma in children, adolescents and young adults: Outcomes according to compliance with international initial care guidelines
- (2019) C. Collignon et al. EJSO
- A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
- (2019) Sheri L Spunt et al. LANCET ONCOLOGY
- Epigenetic Targets in Synovial Sarcoma: A Mini-Review
- (2019) Ryland Hale et al. Frontiers in Oncology
- Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE
- (2018) N Gaspar et al. ANNALS OF ONCOLOGY
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience
- (2018) Daniel Orbach et al. Cancer Medicine
- Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
- (2018) Alexandra Pender et al. MEDICAL ONCOLOGY
- PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
- (2018) Sietse J Luk et al. OncoImmunology
- A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation
- (2018) Brittany C. Michel et al. NATURE CELL BIOLOGY
- Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
- (2018) Gerard L Brien et al. eLife
- Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group
- (2017) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
- First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient
- (2017) Seth M. Pollack et al. JOURNAL OF IMMUNOTHERAPY
- Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts
- (2017) Winette T A van der Graaf et al. LANCET ONCOLOGY
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Response to Pazopanib in Two Pediatric Patients with Pretreated Relapsing Synovial Sarcoma
- (2017) Michela Casanova et al. TUMORI
- Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent
- (2017) Anke E.M. van Erp et al. Oncotarget
- Response to Pazopanib in Two Pediatric Patients with Pretreated Relapsing Synovial Sarcoma
- (2017) Michela Casanova et al. TUMORI JOURNAL
- Synovial Sarcoma Recurrence in Children and Young Adults
- (2016) Monika Scheer et al. ANNALS OF SURGICAL ONCOLOGY
- Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study
- (2016) Barbara C. Worst et al. EUROPEAN JOURNAL OF CANCER
- Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
- (2016) Laetitia J. Martin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Olivier Mir et al. LANCET ONCOLOGY
- Dynamics of BAF–Polycomb complex opposition on heterochromatin in normal and oncogenic states
- (2016) Cigall Kadoch et al. NATURE GENETICS
- The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis
- (2016) K B Jones et al. ONCOGENE
- The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials
- (2016) Sabine Stegmaier et al. PEDIATRIC BLOOD & CANCER
- Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma
- (2016) Theodore S. Nowicki et al. Cancer Immunology Research
- Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro
- (2016) Jacson K. Shen et al. Scientific Reports
- Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma
- (2015) Jonathan Noujaim et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Trabectedin in advanced synovial sarcomas
- (2015) Roberta Sanfilippo et al. ANTI-CANCER DRUGS
- Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
- (2015) Natalie H. Theodoulou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Next generation sequencing in synovial sarcoma reveals novel gene mutations
- (2015) Myrella Vlenterie et al. Oncotarget
- Considering chemotherapy in synovial sarcoma
- (2015) Andrea Ferrari et al. Expert Opinion on Orphan Drugs
- Response to chemotherapy is not related to chromosome instability in synovial sarcoma
- (2014) C. Chakiba et al. ANNALS OF ONCOLOGY
- Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)
- (2014) A. Ferrari et al. ANNALS OF ONCOLOGY
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Synovial sarcoma relapses in children and adolescents: Prognostic factors, treatment, and outcome
- (2014) Frederick Soole et al. PEDIATRIC BLOOD & CANCER
- Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
- (2013) Cigall Kadoch et al. CELL
- Chromosome Instability Accounts for Reverse Metastatic Outcomes of Pediatric and Adult Synovial Sarcomas
- (2013) Pauline Lagarde et al. JOURNAL OF CLINICAL ONCOLOGY
- Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics
- (2012) Le Su et al. CANCER CELL
- Synovial sarcoma in children and adolescents: A critical reappraisal of staging investigations in relation to the rate of metastatic involvement at diagnosis
- (2012) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
- Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma
- (2012) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- NY-ESO-1 expression in sarcomas
- (2012) Jin-Ping Lai et al. OncoImmunology
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: Experience of the International Society of pediatric oncology, malignant mesenchymal tumors (SIOP-MMT) Working Group
- (2011) Daniel Orbach et al. PEDIATRIC BLOOD & CANCER
- Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database
- (2011) Andrea Ferrari et al. PEDIATRIC BLOOD & CANCER
- Synovial sarcoma in childhood and adolescence: A retrospective series of 77 patients registered by the Children's Cancer and Leukaemia Group between 1991 and 2006
- (2010) Bernadette Brennan et al. PEDIATRIC BLOOD & CANCER
- Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: Feasibility and efficacy in refractory pediatric sarcoma
- (2010) Cristina Meazza et al. PEDIATRIC BLOOD & CANCER
- Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005
- (2009) Iyad Sultan et al. CANCER
- Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group
- (2008) A. Italiano et al. ANNALS OF ONCOLOGY
- A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients
- (2008) R. J. Canter et al. CLINICAL CANCER RESEARCH
- Synovial sarcoma of children and adolescents: The prognostic role of axial sites
- (2008) Andrea Ferrari et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started